Literature DB >> 18554750

Reduced ability of C-type natriuretic peptide (CNP) to activate natriuretic peptide receptor B (NPR-B) causes dwarfism in lbab -/- mice.

Andrea R Yoder1, Andrew C Kruse, Cathleen A Earhart, Douglas H Ohlendorf, Lincoln R Potter.   

Abstract

C-type natriuretic peptide (CNP) stimulates endochondrial ossification by activating the transmembrane guanylyl cyclase, natriuretic peptide receptor-B (NPR-B). Recently, a spontaneous autosomal recessive mutation that causes severe dwarfism in mice was identified. The mutant, called long bone abnormality (lbab), contains a single point mutation that converts an arginine to a glycine in a conserved coding region of the CNP gene, but how this mutation affects CNP activity has not been reported. Here, we determined that 30-fold to greater than 100-fold more CNP(lbab) was required to activate NPR-B as compared to wild-type CNP in whole cell cGMP elevation and membrane guanylyl cyclase assays. The reduced ability of CNP(lbab) to activate NPR-B was explained, at least in part, by decreased binding since 10-fold more CNP(lbab) than wild-type CNP was required to compete with [125I][Tyr0]CNP for receptor binding. Molecular modeling suggested that the conserved arginine is critical for binding to an equally conserved acidic pocket in NPR-B. These results indicate that reduced binding to and activation of NPR-B causes dwarfism in lbab(-/-) mice.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18554750      PMCID: PMC4429774          DOI: 10.1016/j.peptides.2008.04.020

Source DB:  PubMed          Journal:  Peptides        ISSN: 0196-9781            Impact factor:   3.750


  33 in total

1.  Lysophosphatidic acid inhibits C-type natriuretic peptide activation of guanylyl cyclase-B.

Authors:  Sarah E Abbey; Lincoln R Potter
Journal:  Endocrinology       Date:  2003-01       Impact factor: 4.736

Review 2.  Guanylyl cyclase receptors.

Authors:  D L Garbers; D Koesling; G Schultz
Journal:  Mol Biol Cell       Date:  1994-01       Impact factor: 4.138

3.  The natriuretic peptide clearance receptor locally modulates the physiological effects of the natriuretic peptide system.

Authors:  N Matsukawa; W J Grzesik; N Takahashi; K N Pandey; S Pang; M Yamauchi; O Smithies
Journal:  Proc Natl Acad Sci U S A       Date:  1999-06-22       Impact factor: 11.205

4.  Interaction of fibroblast growth factor and C-natriuretic peptide signaling in regulation of chondrocyte proliferation and extracellular matrix homeostasis.

Authors:  Pavel Krejci; Bernard Masri; Vincent Fontaine; Pertchoui B Mekikian; Maryann Weis; Herve Prats; William R Wilcox
Journal:  J Cell Sci       Date:  2005-10-18       Impact factor: 5.285

5.  Identification and characterization of the major phosphorylation sites of the B-type natriuretic peptide receptor.

Authors:  L R Potter; T Hunter
Journal:  J Biol Chem       Date:  1998-06-19       Impact factor: 5.157

6.  Binding of CNP-22 and CNP-53 to cultured mouse astrocytes and effects on cyclic GMP.

Authors:  V T Yeung; S K Ho; M G Nicholls; C S Cockram
Journal:  Peptides       Date:  1996       Impact factor: 3.750

7.  Mutations in the transmembrane natriuretic peptide receptor NPR-B impair skeletal growth and cause acromesomelic dysplasia, type Maroteaux.

Authors:  Cynthia F Bartels; Hulya Bükülmez; Pius Padayatti; David K Rhee; Conny van Ravenswaaij-Arts; Richard M Pauli; Stefan Mundlos; David Chitayat; Ling-Yu Shih; Lihadh I Al-Gazali; Sarina Kant; Trevor Cole; Jenny Morton; Valérie Cormier-Daire; Laurence Faivre; Melissa Lees; Jeremy Kirk; Geert R Mortier; Jules Leroy; Bernhard Zabel; Chong Ae Kim; Yanick Crow; Nancy E Braverman; Focco van den Akker; Matthew L Warman
Journal:  Am J Hum Genet       Date:  2004-05-14       Impact factor: 11.025

8.  Intact kinase homology domain of natriuretic peptide receptor-B is essential for skeletal development.

Authors:  Rumi Hachiya; Yuko Ohashi; Yasutomi Kamei; Takayoshi Suganami; Hiroshi Mochizuki; Norimasa Mitsui; Masaaki Saitoh; Masako Sakuragi; Gen Nishimura; Hirofumi Ohashi; Tomonobu Hasegawa; Yoshihiro Ogawa
Journal:  J Clin Endocrinol Metab       Date:  2007-07-24       Impact factor: 5.958

9.  Overexpression of CNP in chondrocytes rescues achondroplasia through a MAPK-dependent pathway.

Authors:  Akihiro Yasoda; Yasato Komatsu; Hideki Chusho; Takashi Miyazawa; Ami Ozasa; Masako Miura; Tatsuya Kurihara; Tomohiro Rogi; Shoji Tanaka; Michio Suda; Naohisa Tamura; Yoshihiro Ogawa; Kazuwa Nakao
Journal:  Nat Med       Date:  2003-12-14       Impact factor: 53.440

Review 10.  C-natriuretic peptide: an important regulator of cartilage.

Authors:  Katerina Pejchalova; Pavel Krejci; William R Wilcox
Journal:  Mol Genet Metab       Date:  2007-08-06       Impact factor: 4.797

View more
  10 in total

Review 1.  Regulation and therapeutic targeting of peptide-activated receptor guanylyl cyclases.

Authors:  Lincoln R Potter
Journal:  Pharmacol Ther       Date:  2010-12-24       Impact factor: 12.310

2.  ATP potentiates competitive inhibition of guanylyl cyclase A and B by the staurosporine analog, Gö6976: reciprocal regulation of ATP and GTP binding.

Authors:  Jerid W Robinson; Lincoln R Potter
Journal:  J Biol Chem       Date:  2011-08-02       Impact factor: 5.157

Review 3.  NPR-C: a component of the natriuretic peptide family with implications in human diseases.

Authors:  Speranza Rubattu; Sebastiano Sciarretta; Angelica Morriello; Camilla Calvieri; Allegra Battistoni; Massimo Volpe
Journal:  J Mol Med (Berl)       Date:  2010-06-19       Impact factor: 4.599

4.  Heterozygous mutations in natriuretic peptide receptor-B (NPR2) gene as a cause of short stature.

Authors:  Sophie R Wang; Christina M Jacobsen; Heather Carmichael; Aaron B Edmund; Jerid W Robinson; Robert C Olney; Timothy C Miller; Jennifer E Moon; Veronica Mericq; Lincoln R Potter; Matthew L Warman; Joel N Hirschhorn; Andrew Dauber
Journal:  Hum Mutat       Date:  2015-03-16       Impact factor: 4.878

5.  Skeletal overgrowth-causing mutations mimic an allosterically activated conformation of guanylyl cyclase-B that is inhibited by 2,4,6,-trinitrophenyl ATP.

Authors:  Deborah M Dickey; Neil M Otto; Lincoln R Potter
Journal:  J Biol Chem       Date:  2017-04-27       Impact factor: 5.157

6.  Systemic administration of C-type natriuretic peptide as a novel therapeutic strategy for skeletal dysplasias.

Authors:  Akihiro Yasoda; Hidetomo Kitamura; Toshihito Fujii; Eri Kondo; Naoaki Murao; Masako Miura; Naotetsu Kanamoto; Yasato Komatsu; Hiroshi Arai; Kazuwa Nakao
Journal:  Endocrinology       Date:  2009-03-12       Impact factor: 4.736

Review 7.  Natriuretic peptides: their structures, receptors, physiologic functions and therapeutic applications.

Authors:  Lincoln R Potter; Andrea R Yoder; Darcy R Flora; Laura K Antos; Deborah M Dickey
Journal:  Handb Exp Pharmacol       Date:  2009

8.  C-type natriuretic peptide (CNP) is a bifurcation factor for sensory neurons.

Authors:  Hannes Schmidt; Agne Stonkute; René Jüttner; Doris Koesling; Andreas Friebe; Fritz G Rathjen
Journal:  Proc Natl Acad Sci U S A       Date:  2009-09-17       Impact factor: 11.205

9.  Guanylyl cyclases A and B are asymmetric dimers that are allosterically activated by ATP binding to the catalytic domain.

Authors:  Jerid W Robinson; Lincoln R Potter
Journal:  Sci Signal       Date:  2012-09-04       Impact factor: 8.192

10.  Mutations in C-natriuretic peptide (NPPC): a novel cause of autosomal dominant short stature.

Authors:  Alfonso Hisado-Oliva; Alba Ruzafa-Martin; Lucia Sentchordi; Mariana F A Funari; Carolina Bezanilla-López; Marta Alonso-Bernáldez; Jimena Barraza-García; Maria Rodriguez-Zabala; Antonio M Lerario; Sara Benito-Sanz; Miriam Aza-Carmona; Angel Campos-Barros; Alexander A L Jorge; Karen E Heath
Journal:  Genet Med       Date:  2017-06-28       Impact factor: 8.822

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.